Evaluation of patient- and treatment-related factors in patients with venous thromboembolism managed within a pediatric cancer center
NCODA Oncology and Hematology Meeting Abstracts · 28.10.2026 · 2 (2)
DOI: 10.67209/xoiq7993 ↗Kurz gefasst
Fachartikel in der Zeitschrift NCODA Oncology and Hematology Meeting Abstracts, online erschienen am 28.10.2026. Verfasst von Michelle Nieland und 3 weiteren Autor:innen. Die Arbeit nennt 1 Literaturangaben.
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
Background
Pediatric oncology patients are at increased risk for cancer-associated thromboembolism, leading to an increased risk of morbidity and mortality. The incidence of cancer-associated thrombosis in this population has been reported to be as high as 16% for symptomatic cases and 40% for asymptomatic cases. Pediatric patients with malignancies are particularly susceptible to developing venous thromboembolism (VTE) due to factors such as active malignancy, mass effect, chemotherapy and asparaginase exposure, central venous catheter use, and surgery. However, despite known risk factors, there are no recognized guidelines for the use of primary thromboprophylaxis among pediatric patients receiving cancer-directed therapy.
Objectives
Discuss current literature on thromboprophylaxis recommendations for pediatric oncology patients. Identify trends in patient- and treatment-related factors associated with VTE development during cancer-directed therapy. Evaluate current institutional thromboprophylaxis guidelines for pediatric oncology patients.
Purpose
The aim of this study is to assess trends in patient and treatment-related factors and evaluate pharmacologic prophylaxis regimens for VTE in pediatric oncology patients diagnosed with thrombosis during cancer-directed therapy.
Methods
This single-center retrospective study evaluated patients 0-26 years old who developed VTE while undergoing cancer-directed therapy from January 2019 to June 2024. Patients were treated within a pediatric academic medical center. Data related to patient demographics, VTE diagnosis, and use of antithrombotic prophylaxis regimens were collected via electronic health record reports and manual chart review. Additionally, known pediatric VTE risk factors, including central venous access, surgical history, and asparaginase administration, were collected.
Results
53 patients were included, with a mean body mass index of 22 kg/m2 (±7.5). The most prevalent VTE was deep vein thrombosis, reported in 32 patients (60%); 50 patients (94%) had central venous access placement within 1 week prior to VTE; and the most common oncologic disease state was acute lymphoblastic leukemia, diagnosed in 21 patients (40%). Approximately 28% of patients who developed VTE received primary thromboprophylaxis. Three patients (6%) received a direct oral anticoagulant, and 12 patients (23%) received enoxaparin.
Conclusion
Patients included in this analysis developed venous thromboembolism while being treated with cancer-directed therapy. Individual risk assessment when evaluating patient- and treatment-related factors is crucial prior to pharmacologic prophylaxis. Further large comparative studies evaluating VTE risk factors in the pediatric oncologic patient population are warranted to determine optimal thromboprophylaxis dosing and regimen. Funding: Not applicable. Prior Presentations: Presented at the Pediatric Pharmacy Association Annual Meeting, April 9–13, 2025, Portland, OR, USA.
Zitieren
APA
Nieland, M., Fillis, C., David, J., & Nuoffer, B. (2026). Evaluation of patient- and treatment-related factors in patients with venous thromboembolism managed within a pediatric cancer center. NCODA Oncology and Hematology Meeting Abstracts, 2(2). https://doi.org/10.67209/xoiq7993
Vancouver
Nieland M, Fillis C, David J, Nuoffer B. Evaluation of patient- and treatment-related factors in patients with venous thromboembolism managed within a pediatric cancer center. NCODA Oncology and Hematology Meeting Abstracts. 2026;2(2). doi:10.67209/xoiq7993
BibTeX
@article{Nieland2026,
author = {Nieland, Michelle and Fillis, Cambree and David, Julia and Nuoffer, Blair},
title = {Evaluation of patient- and treatment-related factors in patients with venous thromboembolism managed within a pediatric cancer center},
journal = {NCODA Oncology and Hematology Meeting Abstracts},
year = {2026},
volume = {2},
number = {2},
doi = {10.67209/xoiq7993}
}
EUVIMED